-
Trials InterruptedCOVID-19 slowed or stopped enrollment in some cancer clinical trials.
by Kate Yandell
-
Registries Report on COVID-19 and CancerData shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
Tests Spot Signs of Cancer in the BloodAt the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer screening and speed up diagnosis.
by Kate Yandell
-
International Perspectives on COVID-19 and CancerResearchers from around the globe share insights into the outcomes of people with cancer who are infected with the coronavirus.
by Bradley Jones
-
Tumor Testing May Help Guide Pancreatic Cancer TreatmentFor a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.
by Cheryl Platzman Weinstock
-
Cancer Treatment During a PandemicPeople being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.
by William G. Nelson, MD, PhD
-
Testing Cancer Patients for the CoronavirusCancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
-
Forward Look
Managing Opioid-Related ConstipationPatients may be wary of discussing this common side effect.
by Sue Rochman
-
-
Can CRISPR Deliver?A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
